InMed Pharmaceuticals

MTRI · NASDAQ

$15.61+$4.39 (+39.14%)TodayMarket closed ·
Prev close $11.22

Latest news

  • Press releaseGlobe Newswire

    Mentari Therapeutics Announces Closing of Merger with InMed Pharmaceuticals and Previously Announced $490 Million Financing

  • Press releasePRNewswire

    InMed Pharmaceuticals Completes Closing of Merger with Mentari Therapeutics

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.